MERS coronavirus vaccine (Stemirna Therapeutics)

N/A

Report date: 2025/12/12 17:32:16

Base Information

Drug NameMERS coronavirus vaccine (Stemirna Therapeutics)
Drug Alias NameMERS-CoV mRNA vaccine (Stemirna Therapeutics)MERS-CoV mRNA vaccine (Stemirna Therapeutics)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesStemirna Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesStemirna Therapeutics
Inactive CompaniesN/A
Active IndicationsCoronavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A